In This Week’s Issue:
1. PCORI: On Contracts: We Hear You—How Applicant Feedback Will Improve Our New Funding Cycle, click here to view the blog.
2. PCORI: Moving Forward: The Next Steps for PCORI's Methodology Standards, click here to view the post.
3. Health Affairs: Lessons Learned: Bringing Big Data Analytics To Health Care, click here to view the blog.
4. Inside Health Policy: FDA Drug Center Chief: Legislation Not Needed For Patient-Reported Outcomes Collection, click here to view (subscription required).
5. The Health Care Blog: The Cost-Response Curve, click here to view the post.
6. JAMA: New Opportunities in the Changing Landscape of Prevention, Click here to view the full article.
7. Mayo Clinic: Modernizing the Clinical Trial System to Meet the Needs of Patients, click here for the blog and video of testimony
1. PCORI: On Contracts: We Hear You—How Applicant Feedback Will Improve Our New Funding Cycle, click here to view the blog.
2. PCORI: Moving Forward: The Next Steps for PCORI's Methodology Standards, click here to view the post.
3. Health Affairs: Lessons Learned: Bringing Big Data Analytics To Health Care, click here to view the blog.
4. Inside Health Policy: FDA Drug Center Chief: Legislation Not Needed For Patient-Reported Outcomes Collection, click here to view (subscription required).
5. The Health Care Blog: The Cost-Response Curve, click here to view the post.
6. JAMA: New Opportunities in the Changing Landscape of Prevention, Click here to view the full article.
7. Mayo Clinic: Modernizing the Clinical Trial System to Meet the Needs of Patients, click here for the blog and video of testimony
1. PCORI: On Contracts: We Hear You—How Applicant Feedback Will Improve Our New Funding Cycle
Writing last week for the PCORI Blog, James Hulbert, Kara Odom Walker, and Tsahai Tafari, addressed researcher-voiced concerns regarding new PFAs. “Our Fall 2014 Funding Cycle will open on August 6 with the posting of five broad PCORI Funding Announcements (PFAs). In preparing those PFAs, we used the feedback received from previous applicants to improve and simplify the application process and provide greater clarity on the topics we are most interested in funding. This should help you determine whether your proposed project is appropriate to a given PFA.” Click here to view the blog.
2. PCORI: Moving Forward: The Next Steps for PCORI's Methodology Standards
David Hickam and Katie Rader wrote a post for the PCORI Blog last week commenting on the organization’s efforts surrounding research methodology. “The Methodology Committee is taking three approaches to developing additional standards and endorsing standards of other organizations.[…]The first strategy is to focus on gaps in our current set of standards.[…]In a second strategy, the Committee is examining standards and guidelines offered by other organizations.[...]Finally, we are asking the full range of healthcare stakeholders to suggest topics for new standards.” Click here to view the post.
3. Health Affairs: Lessons Learned: Bringing Big Data Analytics To Health Care
Authors Steven Escaravage and Joachim Roski discuss the “learning curve” that is the use of big data for patient care. “We've found that many organizations, eager to get started on a big data project, often quickly gather and use the data that is the easiest to obtain, without considering whether it really goes to the heart of the specific health care problem they're investigating. While this can speed up a project, the analytic results are likely to have only limited value.” Click here to view the blog.
4. Inside Health Policy: FDA Drug Center Chief: Legislation Not Needed For Patient-Reported Outcomes Collection
Stephanie Beasley at Inside Health Policy reported last week about Food and Drug Administration’s lack of desire for legislation regarding patient-reported outcomes. “FDA drug center chief Janet Woodcock told the House Energy and Commerce health panel Friday that legislation is not needed to help the agency better incorporate patient-reported outcomes in the drug development process. Instead, she said, FDA could engage patients and industry to develop standards for soliciting patient perspectives, and to develop validated tools to measure patients' risk tolerance.” Click here to view (subscription required).
5. The Health Care Blog: The Cost-Response Curve
The Health Care Blog published a piece by Leonard Kish and Kevin O'Brien recently. The authors commented on patients’ ability to pay for their prescriptions and the cost to the health care system when they can’t. “27% of Americans did not fulfill a prescription due to financial hardship in 2012 according to a Kaiser Family Survey. As copays, deductibles and out-of-pocket expenses go up, so, likely, will non-adherence, and value-based care, and value-based benefits must understand the costs related to non-adherence.” Click here to view the post.
6. JAMA: New Opportunities in the Changing Landscape of Prevention
JAMA’s recent issue of Viewpoint featured Derek Yach and Chris Calitz commenting on additional recommendations for PCORI. “Low levels of investment in prevention research and development represent a missed opportunity to further scientific knowledge and improve population health. [...] PCORI-funded research could be an important avenue for establishing an evidence base for cost-effective prevention interventions.” Click here to view the full article.
7. Mayo Clinic: Modernizing the Clinical Trial System to Meet the Needs of Patients
Sundeep Khosla of the Mayo Clinic penned an article for the hospital’s Future of Health Care Blog. In it, he relayed his recommendation presented recently to congress urging them to keep patients in mind as they plot out guidelines for clinical trials. “I offered four potential areas of policy focus for the Congress to consider, which could assist in modernizing clinical trials [...] 3. Provide sufficient privacy protections to leverage the immense value of electronic health records for the benefit of clinical trials and critical outcomes research, including comparative-effectiveness research.” Click here for the blog and video of testimony.
Writing last week for the PCORI Blog, James Hulbert, Kara Odom Walker, and Tsahai Tafari, addressed researcher-voiced concerns regarding new PFAs. “Our Fall 2014 Funding Cycle will open on August 6 with the posting of five broad PCORI Funding Announcements (PFAs). In preparing those PFAs, we used the feedback received from previous applicants to improve and simplify the application process and provide greater clarity on the topics we are most interested in funding. This should help you determine whether your proposed project is appropriate to a given PFA.” Click here to view the blog.
2. PCORI: Moving Forward: The Next Steps for PCORI's Methodology Standards
David Hickam and Katie Rader wrote a post for the PCORI Blog last week commenting on the organization’s efforts surrounding research methodology. “The Methodology Committee is taking three approaches to developing additional standards and endorsing standards of other organizations.[…]The first strategy is to focus on gaps in our current set of standards.[…]In a second strategy, the Committee is examining standards and guidelines offered by other organizations.[...]Finally, we are asking the full range of healthcare stakeholders to suggest topics for new standards.” Click here to view the post.
3. Health Affairs: Lessons Learned: Bringing Big Data Analytics To Health Care
Authors Steven Escaravage and Joachim Roski discuss the “learning curve” that is the use of big data for patient care. “We've found that many organizations, eager to get started on a big data project, often quickly gather and use the data that is the easiest to obtain, without considering whether it really goes to the heart of the specific health care problem they're investigating. While this can speed up a project, the analytic results are likely to have only limited value.” Click here to view the blog.
4. Inside Health Policy: FDA Drug Center Chief: Legislation Not Needed For Patient-Reported Outcomes Collection
Stephanie Beasley at Inside Health Policy reported last week about Food and Drug Administration’s lack of desire for legislation regarding patient-reported outcomes. “FDA drug center chief Janet Woodcock told the House Energy and Commerce health panel Friday that legislation is not needed to help the agency better incorporate patient-reported outcomes in the drug development process. Instead, she said, FDA could engage patients and industry to develop standards for soliciting patient perspectives, and to develop validated tools to measure patients' risk tolerance.” Click here to view (subscription required).
5. The Health Care Blog: The Cost-Response Curve
The Health Care Blog published a piece by Leonard Kish and Kevin O'Brien recently. The authors commented on patients’ ability to pay for their prescriptions and the cost to the health care system when they can’t. “27% of Americans did not fulfill a prescription due to financial hardship in 2012 according to a Kaiser Family Survey. As copays, deductibles and out-of-pocket expenses go up, so, likely, will non-adherence, and value-based care, and value-based benefits must understand the costs related to non-adherence.” Click here to view the post.
6. JAMA: New Opportunities in the Changing Landscape of Prevention
JAMA’s recent issue of Viewpoint featured Derek Yach and Chris Calitz commenting on additional recommendations for PCORI. “Low levels of investment in prevention research and development represent a missed opportunity to further scientific knowledge and improve population health. [...] PCORI-funded research could be an important avenue for establishing an evidence base for cost-effective prevention interventions.” Click here to view the full article.
7. Mayo Clinic: Modernizing the Clinical Trial System to Meet the Needs of Patients
Sundeep Khosla of the Mayo Clinic penned an article for the hospital’s Future of Health Care Blog. In it, he relayed his recommendation presented recently to congress urging them to keep patients in mind as they plot out guidelines for clinical trials. “I offered four potential areas of policy focus for the Congress to consider, which could assist in modernizing clinical trials [...] 3. Provide sufficient privacy protections to leverage the immense value of electronic health records for the benefit of clinical trials and critical outcomes research, including comparative-effectiveness research.” Click here for the blog and video of testimony.
